Author
Listed:
- Walter H. A. Kahr
(Cell Biology Program, Research Institute, Hospital for Sick Children
University of Toronto and The Hospital for Sick Children
University of Toronto)
- Fred G. Pluthero
(Cell Biology Program, Research Institute, Hospital for Sick Children)
- Abdul Elkadri
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children
Institute of Medical Science, University of Toronto)
- Neil Warner
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children)
- Marko Drobac
(Cell Biology Program, Research Institute, Hospital for Sick Children
University of Toronto)
- Chang Hua Chen
(Cell Biology Program, Research Institute, Hospital for Sick Children
University of Toronto)
- Richard W. Lo
(Cell Biology Program, Research Institute, Hospital for Sick Children
University of Toronto)
- Ling Li
(Cell Biology Program, Research Institute, Hospital for Sick Children)
- Ren Li
(Cell Biology Program, Research Institute, Hospital for Sick Children)
- Qi Li
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children)
- Cornelia Thoeni
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children)
- Jie Pan
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children)
- Gabriella Leung
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children)
- Irene Lara-Corrales
(The Hospital for Sick Children)
- Ryan Murchie
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children)
- Ernest Cutz
(The Hospital for Sick Children)
- Ronald M. Laxer
(University of Toronto, The Hospital for Sick Children
University of Toronto)
- Julia Upton
(University of Toronto, The Hospital for Sick Children)
- Chaim M. Roifman
(University of Toronto, The Hospital for Sick Children)
- Rae S. M. Yeung
(Cell Biology Program, Research Institute, Hospital for Sick Children
Institute of Medical Science, University of Toronto
University of Toronto, The Hospital for Sick Children
University of Toronto)
- John H Brumell
(Cell Biology Program, Research Institute, Hospital for Sick Children
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children
Institute of Medical Science, University of Toronto
University of Toronto)
- Aleixo M Muise
(Cell Biology Program, Research Institute, Hospital for Sick Children
University of Toronto
Hepatology, and Nutrition, University of Toronto, Hospital for Sick Children
Institute of Medical Science, University of Toronto)
Abstract
Human actin-related protein 2/3 complex (Arp2/3), required for actin filament branching, has two ARPC1 component isoforms, with ARPC1B prominently expressed in blood cells. Here we show in a child with microthrombocytopenia, eosinophilia and inflammatory disease, a homozygous frameshift mutation in ARPC1B (p.Val91Trpfs*30). Platelet lysates reveal no ARPC1B protein and greatly reduced Arp2/3 complex. Missense ARPC1B mutations are identified in an unrelated patient with similar symptoms and ARPC1B deficiency. ARPC1B-deficient platelets are microthrombocytes similar to those seen in Wiskott–Aldrich syndrome that show aberrant spreading consistent with loss of Arp2/3 function. Knockout of ARPC1B in megakaryocytic cells results in decreased proplatelet formation, and as observed in platelets from patients, increased ARPC1A expression. Thus loss of ARPC1B produces a unique set of platelet abnormalities, and is associated with haematopoietic/immune symptoms affecting cell lineages where this isoform predominates. In agreement with recent experimental studies, our findings suggest that ARPC1 isoforms are not functionally interchangeable.
Suggested Citation
Walter H. A. Kahr & Fred G. Pluthero & Abdul Elkadri & Neil Warner & Marko Drobac & Chang Hua Chen & Richard W. Lo & Ling Li & Ren Li & Qi Li & Cornelia Thoeni & Jie Pan & Gabriella Leung & Irene Lara, 2017.
"Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease,"
Nature Communications, Nature, vol. 8(1), pages 1-14, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14816
DOI: 10.1038/ncomms14816
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14816. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.